NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer

• Datum: 2023
• Hauptverfasser: Gaptulbarova, K.A., Tsyganov, M.M., Pevzner, A.M., Ibragimova, M.K., Litviakov, N.V.
• Format: Artikel
• Sprache: Englisch
• Veröffentlicht: PH Akademperiodyka 2023
• Schlagworte: homologous recombination deficiency; marker; NF-kB1; personalized medicine
• Online Zugang: https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-2
• Назва журналу: Experimental Oncology

Summary. The NF-kB1 gene belongs to the family of transcription factors that are involved in the regulation of a wide range of biological reactions. It has been established that NF-kB1 plays an important role in the regulation of immune responses, but more and more studies indicate...